Get startedLog in
    Picture of Shanghai Fosun Pharmaceutical logo

    2196 — Shanghai Fosun Pharmaceutical News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapNeutral
    All News

    Brief: Shanghai Fosun Pharmaceutical's Unit Yaoyou Signs Licensing Agreement With Genrix Biopharmaceutical

    Picture of Shanghai Fosun Pharmaceutical logoShanghai Fosun Pharmaceutical
    28/05/2026 10:32
    BRIEF-Shanghai Fosun Pharmaceutical's Unit Yaoyou Signs Licensing Agreement With Genrix Biopharmaceutical
    May 28 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS:
    • SAYS UNIT YAOYOU PHARMACEUTICAL SIGNED LICENSING AGREEMENT WITH GENRIX BIOPHARMACEUTICAL FOR UP TO 600 MILLION YUAN ($88.50 million) IN UPFRONT, MILESTONE PAYMENTS
    • SAYS GENRIX GRANTED YAOYOU EXCLUSIVE GREATER CHINA RIGHTS TO DEVELOP, COMMERCIALISE AND MANUFACTURE AN ANTIBODY-BASED DRUG PRODUCT
    Source text
    Further company coverage: 600196.SS

    ($1 = 6.7793 Chinese yuan renminbi)

     (Reporting by Beijing Newsroom)
     ((yukun.zhang@thomsonreuters.com;))

    Recent news on Shanghai Fosun Pharmaceutical

    See all news